Paper2868340
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.
Hatton CS and 7 others. Lancet, 1986. Cited by 214 papers, by iCite.
Cite this record
ConductScience Library. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Papers, record 2868340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2868340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agranulocytosis | Major topic |
| Amodiaquine | Major topic |
| Malaria | Major topic |
| Neutropenia | Major topic |
| Acute Disease | |
| Adult | |
| Drug Combinations | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Leukocyte Count | |
| Male | |
| Middle Aged | |
| Proguanil | |
| Retrospective Studies | |
| Sulfaguanidine | |
| Sulfamethoxazole | |
| Travel | |
| Trimethoprim | |
| Trimethoprim, Sulfamethoxazole Drug Combination |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957702 | Parasitological efficacy of sulfadoxine-pyrimethamine and amodiaquine for seasonal malaria chemoprevention in Africa. | Nat Commun | 2026 | https://conductscience.org/library/papers/42957702 | PubMed |
| 40191366 | Aminoquinoline-Pyrimidine-Based Alkyl-Piperazine Tethered Hybrids: Synthesis, Antiplasmodial Activity, and Mechanistic Studies. | ACS Omega | 2025 | https://conductscience.org/library/papers/40191366 | PubMed |
| 39598746 | Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer's Disease. | Molecules | 2024 | https://conductscience.org/library/papers/39598746 | PubMed |
| 37513987 | Novel Therapeutics for Malaria. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37513987 | PubMed |
| 37064987 | Vancomycin-Induced Maturation Arrest with Reactive Promyelocyte Proliferation: A Diagnostic and Therapeutic Challenge. | J Lab Physicians | 2023 | https://conductscience.org/library/papers/37064987 | PubMed |
| 36256474 | Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies. | Br J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/36256474 | PubMed |
| 34926171 | Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients. | Toxicol Rep | 2021 | https://conductscience.org/library/papers/34926171 | PubMed |
| 34492005 | The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. | PLoS Med | 2021 | https://conductscience.org/library/papers/34492005 | PubMed |
| 34218660 | In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax. | ACS Infect Dis | 2021 | https://conductscience.org/library/papers/34218660 | PubMed |
| 33588856 | Influence of cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar. | Malar J | 2021 | https://conductscience.org/library/papers/33588856 | PubMed |
| 33407454 | Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria. | Malar J | 2021 | https://conductscience.org/library/papers/33407454 | PubMed |
| 33163636 | Efficacy of Artemether-Lumefantrine on various Plasmodium falciparum Kelch 13 and Pfmdr1 genes isolated in Ghana. | Parasite Epidemiol Control | 2020 | https://conductscience.org/library/papers/33163636 | PubMed |
| 31097988 | Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ-Pyrimidines. | ACS Med Chem Lett | 2019 | https://conductscience.org/library/papers/31097988 | PubMed |
| 30208056 | Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization. | PLoS One | 2018 | https://conductscience.org/library/papers/30208056 | PubMed |
| 26350723 | Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates. | Chembiochem | 2015 | https://conductscience.org/library/papers/26350723 | PubMed |
| 25888957 | The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. | BMC Med | 2015 | https://conductscience.org/library/papers/25888957 | PubMed |
| 25331702 | JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25331702 | PubMed |
| 23866736 | Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. | Malar J | 2013 | https://conductscience.org/library/papers/23866736 | PubMed |
| 22084530 | Can pharmacogenomics improve malaria drug policy? | Bull World Health Organ | 2011 | https://conductscience.org/library/papers/22084530 | PubMed |
| 21418669 | Malaria: prevention in travellers. | BMJ Clin Evid | 2010 | https://conductscience.org/library/papers/21418669 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2868340
GET https://conductscience.org/api/papers/v1/2868340/cited_by?page=2